How many institutions held TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in Q1 2020?

102 institutional investors reported TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value for Q1 2020. Use the holders table for investor-level position and value details.

Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

Q: What does CUSIP G8807B106 represent in this 13F holders report?

CUSIP G8807B106 is the security identifier for TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value used to aggregate holder disclosures.

CUSIP: G8807B106

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Ordinary Share $0.00001 Par Value
Shares outstanding: 51,428,000
Total 13F shares: 56,904,286
Share change: +11,670,491
Total reported value: $1,315,179,943
Put/Call ratio: 222%
Price per share: $23.11
Number of holders: 102
Value change: +$267,872,903
Number of buys: 66
Number of sells: 36

Quarterly Holders Quick Answers

What is CUSIP G8807B106?
CUSIP G8807B106 identifies TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP G8807B106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAUPOST GROUP LLC/MA	13F	Company	18%	9,309,168	$241,014,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	16%	8,458,657	$218,994,000	—	31 Dec 2019	13F
Link Fund Solutions Ltd	13F	Company	10%	5,251,349	$135,459,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	7.8%	4,003,602	$103,653,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	7.4%	3,829,079	$99,134,000	—	31 Dec 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	6.2%	3,177,537	$82,267,000	—	31 Dec 2019	13F
NORGES BANK	13F	Company	2.1%	1,075,589	$27,847,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	1.9%	959,564	$24,843,000	—	31 Dec 2019	13F
Chescapmanager LLC	13F	Company	1.8%	949,006	$24,570,000	—	31 Dec 2019	13F
Rock Springs Capital Management LP	13F	Company	1.3%	655,200	$16,963,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	611,348	$15,827,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	1.2%	604,855	$15,660,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	1.1%	571,576	$14,798,000	—	31 Dec 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1%	526,438	$13,629,000	—	31 Dec 2019	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.88%	452,615	$11,718,000	—	31 Dec 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.68%	350,581	$9,076,000	—	31 Dec 2019	13F
S.c.a. Candriam	13F	Individual	0.54%	277,700	$7,190,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.53%	271,951	$7,040,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.52%	268,100	$6,942,000	—	31 Dec 2019	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.46%	234,500	$6,071,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.4%	203,368	$5,265,000	—	31 Dec 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.38%	196,617	$5,091,000	—	31 Dec 2019	13F
Rubric Capital Management LP	13F	Company	0.34%	173,400	$4,489,000	—	31 Dec 2019	13F
Newtyn Management, LLC	13F	Company	0.34%	173,300	$4,487,000	—	31 Dec 2019	13F
CREDIT SUISSE AG/	13F	Company	0.29%	148,141	$3,836,000	—	31 Dec 2019	13F
Tekla Capital Management LLC	13F	Company	0.23%	117,725	$3,048,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.23%	116,648	$3,020,000	—	31 Dec 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.2%	100,622	$2,605,000	—	31 Dec 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.2%	100,551	$2,603,000	—	31 Dec 2019	13F
ROYCE & ASSOCIATES LP	13F	Company	0.18%	93,300	$2,416,000	—	31 Dec 2019	13F
Swiss National Bank	13F	Company	0.16%	81,342	$2,106,000	—	31 Dec 2019	13F
Laurion Capital Management LP	13F	Company	0.15%	77,528	$2,007,000	—	31 Dec 2019	13F
CHICAGO EQUITY PARTNERS LLC	13F	Company	0.14%	70,585	$1,827,000	—	31 Dec 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.13%	68,906	$1,784,000	—	31 Dec 2019	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.13%	66,300	$1,717,000	—	31 Dec 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.12%	64,235	$1,663,000	—	31 Dec 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.11%	57,916	$1,499,000	—	31 Dec 2019	13F
BARCLAYS PLC	13F	Company	0.11%	54,689	$1,416,000	—	31 Dec 2019	13F
FIRST TRUST ADVISORS LP	13F	Company	0.1%	50,692	$1,312,000	—	31 Dec 2019	13F
Cormorant Asset Management, LP	13F	Company	0.1%	50,000	$1,295,000	—	31 Dec 2019	13F
MOORE CAPITAL MANAGEMENT, LP	13F	Company	0.1%	50,000	$1,295,000	—	31 Dec 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.08%	42,200	$1,093,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.08%	41,448	$1,070,000	—	31 Dec 2019	13F
NJ State Employees Deferred Compensation Plan	13F	Company	0.07%	38,142	$988,000	—	31 Dec 2019	13F
Engineers Gate Manager LP	13F	Company	0.07%	35,735	$925,000	—	31 Dec 2019	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.07%	33,757	$873,969	—	31 Dec 2019	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.06%	31,476	$815,000	—	31 Dec 2019	13F
VIRTUS ADVISERS, LLC	13F	Company	0.06%	29,216	$756,000	—	31 Dec 2019	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.06%	29,102	$753,000	—	31 Dec 2019	13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	13F	Company	0.06%	28,458	$737,000	—	31 Dec 2019	13F

Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) as of Q1 2020

As of 31 Mar 2020, Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) was held by 102 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,904,286 shares. The largest 10 holders included FMR LLC, BAUPOST GROUP LLC/MA, BlackRock Inc., Link Fund Solutions Ltd, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, AMERIPRISE FINANCIAL INC, NORGES BANK, STATE STREET CORP, and Chescapmanager LLC. This page lists 102 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

103

Q1 2020 holders

102

Holder diff

-1

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.